Author:
Abt Dominik,Mordasini Livio,Hechelhammer Lukas,Kessler Thomas M,Schmid Hans-Peter,Engeler Daniel S
Publisher
Springer Science and Business Media LLC
Subject
Urology,Reproductive Medicine,General Medicine
Reference24 articles.
1. Levy A, Samraj GP: Benign prostatic hyperplasia: when to ‘watch and wait’, when and how to treat. Cleve Clin J Med. 2007, 74 (Suppl 3): S15-S20.
2. Eckhardt MD, Van Venrooij GE, Van Melick HH, Boon TA: Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol. 2001, 166 (2): 563-568. 10.1016/S0022-5347(05)65985-X.
3. Michel MC, Mehlburger L, Bressel HU, Schumacher H, Schafers RF, Goepel M: Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability?. J Urol. 1998, 160 (3 Pt 1): 784-791.
4. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG: Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008, 180 (1): 246-249. 10.1016/j.juro.2008.03.058.
5. Sun F, Sanchez FM, Crisostomo V, Lima JR, Luis L, Garcia-Martinez V, Lopez-Sanchez C, Uson J, Maynar M: Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment–preliminary study in pigs. Radiology. 2008, 246 (3): 783-789. 10.1148/radiol.2463070647.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献